Dihydro-5-fluorouracluorouracil(5-lWH~) , the maiu catabolite of the anticancer drug 54uorouraeil( WU), can be quantitated iu human serum simultaueously with the pro-drug 5'-deoxy-5-f (5'dFWR), the parent drug 5-PU and the aaabolites 5-fluorouridine and 2'-deoxy-5-f by gradient elution-reversed phas
Simultaneous determination of 5′-deoxy-5-fluorouridine, 5-fluorouracil and 5,6-dihydro-5-fluorouracil in plasma by gas chromatography-mass spectrometry
✍ Scribed by Carlo G. Zambonin; Antonio Guerrieri; Francesco Palmisano
- Publisher
- Elsevier Science
- Year
- 1996
- Tongue
- English
- Weight
- 779 KB
- Volume
- 329
- Category
- Article
- ISSN
- 0003-2670
No coin nor oath required. For personal study only.
✦ Synopsis
A gas chromatography-mass spectrometry (GC-MS) method for the simultaneous determination of 5'-deoxy-Sfluorouridine (doxifluridine, 5'-dFUR), 5fluorouracil (5-FU) and its main catabolite 5,6-dihydro-5-fluorouracil
(5-FUH*) in human plasma has been developed. Sample preparation consisted of protein precipitation with ammonium sulphate followed by analyte extraction with ethyl acetate/isopropanol (90/10, v/v) mixture. Extracts were then analysed by GC-MS in positive electron impact mode after derivatization with N,O-bis(trimethylsilyl)trifluoroacetamide/pyridine (l/l, v/v). The trimethylsilyl (TMS) derivative of 5'-dFWR was proved to be stable so that no interference in 5-FU determination was observed. Mass spectra of TMS derivatives of 5'-dFUR, 5-FU and 5-FWH2 are discussed. Analyte response was linear over two decades of concentration and detection limits were typically 20ng/ml of plasma.
📜 SIMILAR VOLUMES
N,O-bis(trimethylsilyl)trifluoroacetamide, N-methyl-N-(tert-butyldimethylsilyl)trifluoroacetamide and trifluoroacetic anhydride have been investigated as derivatizing agents for GC/MS determination of N 3 -methyl-5'-deoxy-5-fluorouridine (N 3 -Me-5'-dFUR), a metabolic product of the anticancer pro-d